Tsumura & Co 2023 IR
The report outlines Tsumura & Co.'s value creation journey and its long-term management vision, TSUMURA VISION 'Cho-WA' 2031. Key highlights include the company's efforts to standardize and personalize Kampo treatments in Japan and expand its traditional Chinese medicine business in China. The company also details its sustainability initiatives, focusing on carbon neutrality, water risk mitigation, and biodiversity preservation, particularly through the sustainable procurement of raw material crude drugs under the Tsumura GACP guidelines.
Company: Tsumura & Co
Sector: Health Care
Country: Japan
Year: 2023
Type: IR
Pages: 80
Tsumura & Co
Integrated Report
The report outlines Tsumura & Co.'s value creation journey and its long-term management vision, TSUMURA VISION 'Cho-WA' 2031. Key highlights include the company's efforts to standardize and personalize Kampo treatments in Japan and expand its traditional Chinese medicine business in China. The company also details its sustainability initiatives, focusing on carbon neutrality, water risk mitigation, and biodiversity preservation, particularly through the sustainable procurement of raw material crude drugs under the Tsumura GACP guidelines.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Net Zero Target
Employees